Antimicrobial Agents Practice Questions

Q: All of the following are common adverse effects of HAART therapy except?

Optic neuritis. Highly Active Antiretroviral Therapy (HAART) is associated with a specific cluster of metabolic and mitochondrial toxicities. **Explanation of the Correct Answer:** **Optic neuritis (Option C)** is **not** a common adverse effect of HAART. While it is a classic side effect of **Ethambutol** (used in TB) or certain infections like CMV in HIV patients, it is not typically caused by antiretroviral drugs. **Explanation of Incorrect Options:** * **Steatosis (Option A):** Nucleoside Reverse Transcriptase Inhibitors (NRTIs), especially Zidovudine, Stavudine, and Didanosine, cause **mitochondrial toxicity** by inhibiting DNA polymerase-gamma. This leads to lactic acidosis and hepatic steatosis (fatty liver). * **Lipodystrophy (Option B):** This is a hallmark side effect of HAART, characterized by "Cushingoid" fat redistribution (buffalo hump, abdominal obesity) and peripheral fat wasting. It is most commonly associated with **Protease Inhibitors (PIs)** and certain NRTIs (Stavudine). * **Increased Cholesterol (Option D):** Dyslipidemia (elevated triglycerides and LDL) is a very common metabolic complication of **Protease Inhibitors** (e.g., Ritonavir, Lopinavir), which interfere with lipid metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for NRTI toxicity:** "L-M-N" (Lactic acidosis, Mitochondrial toxicity, Nucleoside analogs). * **Zidovudine:** Most common side effect is **Anemia/Bone marrow suppression**. * **Abacavir:** Associated with **Hypersensitivity reactions** (linked to HLA-B*5701). * **Nevirapine:** Known for causing **Stevens-Johnson Syndrome (SJS)** and hepatotoxicity. * **Indinavir:** Associated with **Nephrolithiasis** (kidney stones). * **Tenofovir:** Can cause **Fanconi syndrome** (renal tubular acidosis).

Q: Reactivation of Varicella-Zoster Virus (VZV) is known to occur in persons receiving immunosuppressive therapy. Which of the following is the best antiviral for treating this infection?

Valacyclovir. **Explanation:** The question describes **Herpes Zoster (Shingles)**, which is the reactivation of the latent Varicella-Zoster Virus (VZV) within the sensory ganglia. In immunocompromised patients, prompt antiviral therapy is crucial to prevent cutaneous dissemination and visceral complications. **Why Valacyclovir is the Correct Choice:** Valacyclovir is the prodrug of Acyclovir. It is the preferred treatment for VZV reactivation because it has **superior oral bioavailability** compared to Acyclovir, leading to higher serum concentrations and less frequent dosing (TID vs. 5 times/day). It acts by inhibiting viral DNA polymerase after being phosphorylated by viral thymidine kinase. **Analysis of Incorrect Options:** * **Amantadine:** An M2 ion channel blocker formerly used for Influenza A. It has no activity against DNA viruses like VZV. * **Boceprevir:** A protease inhibitor used specifically in the treatment of Chronic Hepatitis C (HCV) genotype 1. * **Ribavirin:** A guanosine analogue used primarily for RSV (aerosolized) and Chronic Hepatitis C (in combination with interferon). It is not indicated for VZV. **High-Yield Clinical Pearls for NEET-PG:** * **Tzanck Smear:** A rapid bedside test showing **Multinucleated Giant Cells** with Cowdry Type A intranuclear inclusions (seen in both HSV and VZV). * **Post-Herpetic Neuralgia (PHN):** The most common complication of Shingles; early treatment with Valacyclovir reduces its duration. * **Ramsay Hunt Syndrome:** Reactivation of VZV in the geniculate ganglion, presenting with facial palsy and vesicles in the external auditory canal. * **Drug of Choice for Disseminated VZV:** Intravenous (IV) Acyclovir is preferred over oral routes in severe or disseminated cases.

Q: Which of the following drugs is not required in the treatment of cysticercosis?

Ketoconazole. **Explanation:** The management of **Cysticercosis** (infection by the larval stage of *Taenia solium*) involves a combination of antiparasitic drugs, corticosteroids, and anticonvulsants. **Why Ketoconazole is the correct answer:** **Ketoconazole** is an antifungal agent that inhibits ergosterol synthesis. It has no activity against helminths or the larvae of *Taenia solium*. Furthermore, Ketoconazole is a potent **CYP450 inhibitor**. This is clinically significant because it can interfere with the metabolism of other drugs, but it plays no therapeutic role in treating cysticercosis. **Analysis of other options:** * **Albendazole (Option A):** This is the **drug of choice** for neurocysticercosis. It is a cysticidal agent that crosses the blood-brain barrier effectively to kill the larvae. * **Praziquantel (Option B):** Another potent anthelmintic used as an alternative or adjunct to Albendazole. It increases the permeability of the parasite cell membrane to calcium, leading to paralysis and death of the cyst. * **Levetiracetam (Option C):** Seizures are the most common clinical presentation of neurocysticercosis. **Antiepileptic drugs (AEDs)** like Levetiracetam, Carbamazepine, or Phenytoin are essential to manage and prevent seizures during the inflammatory phase of treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Steroids First:** Always administer corticosteroids (e.g., Dexamethasone) *before* starting antiparasitic drugs to prevent a severe inflammatory response (Herxheimer-like reaction) caused by dying cysts in the brain. * **Drug Interaction:** Phenytoin and Carbamazepine (enzyme inducers) can **decrease** the plasma levels of Praziquantel and Albendazole. * **Ocular Cysticercosis:** Antiparasitic drugs are generally **contraindicated** in intraocular cysticercosis as the resulting inflammation can cause permanent blindness; surgical removal is preferred.

Q: Which of the following statement is not true regarding dapsone?

Poor oral absorption. **Explanation:** Dapsone (Diaminodiphenyl sulfone) is the cornerstone of multidrug therapy (MDT) for leprosy. The statement "Poor oral absorption" is **incorrect** because Dapsone is actually **well-absorbed** from the gastrointestinal tract, with nearly 100% bioavailability. It is widely distributed in the body and undergoes enterohepatic circulation. **Analysis of other options:** * **Option A (Mechanism of Action):** Dapsone is a structural analog of PABA. It acts by competitively inhibiting the enzyme **dihydropteroate synthase**, thereby blocking folic acid synthesis in *M. leprae*. This is the same mechanism as sulfonamides. * **Option C (DDS Syndrome):** Also known as "Sulfone Syndrome," this is a severe hypersensitivity reaction occurring 4–6 weeks after starting therapy. It is characterized by fever, malaise, exfoliative dermatitis, jaundice, and lymphadenopathy. * **Option D (Hemolysis):** Dapsone causes oxidative stress. It can lead to dose-related hemolysis, especially in patients with **G6PD deficiency**. It is also frequently associated with methemoglobinemia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Dapsone is used for Leprosy, Dermatitis Herpetiformis, and *Pneumocystis jirovecii* prophylaxis. * **Metabolism:** It is metabolized via **acetylation** (similar to Isoniazid and Hydralazine). * **Side Effects:** Remember the triad of **Hemolysis, Methemoglobinemia, and Sulfone Syndrome.** * **Lepra Reactions:** Dapsone is continued during Type 1 and Type 2 lepra reactions.

Q: Pseudojaundice is an adverse effect of which of the following drugs?

Rifabutin. **Explanation:** **Pseudojaundice** refers to a yellowish-orange discoloration of the skin and mucous membranes without an elevation in serum bilirubin levels. Unlike true jaundice, the sclera is typically spared. **Correct Option: B. Rifabutin** Rifabutin, a rifamycin derivative used primarily in the treatment of *Mycobacterium avium* complex (MAC) and tuberculosis, is known to cause a harmless, reversible yellowish-orange discoloration of the skin, urine, and secretions. This phenomenon is termed **pseudojaundice**. It occurs due to the drug’s inherent pigment and its metabolites. It is important to distinguish this from drug-induced hepatitis, where scleral icterus and elevated liver enzymes would be present. **Incorrect Options:** * **A. Phenytoin:** Known for causing gingival hyperplasia, hirsutism, and Stevens-Johnson Syndrome (SJS), but not pseudojaundice. * **C. Omeprazole:** A Proton Pump Inhibitor (PPI) commonly associated with hypomagnesemia and B12 deficiency; it does not cause skin discoloration. * **D. Chlorpromazine:** This antipsychotic can cause a **blue-gray skin pigmentation** in sun-exposed areas and corneal/lens opacities, but not yellowing. **High-Yield Clinical Pearls for NEET-PG:** * **Other causes of Pseudojaundice:** Excessive intake of Beta-carotene (Carotenemia) and drugs like **Quinacrine**. * **Rifampin vs. Rifabutin:** While both discolor secretions (orange urine), Rifabutin is more specifically linked to the clinical term "pseudojaundice" and **uveitis** (a dose-dependent side effect). * **Scleral Sparing:** The hallmark of pseudojaundice is that the **sclera remains white**, whereas in true jaundice (icterus), the sclera is the first site to turn yellow due to high elastin content's affinity for bilirubin.

Q: Which antitubercular drug causes hepatic adaptation?

Isoniazid. ### Explanation **Correct Option: A (Isoniazid)** Hepatic adaptation refers to a transient, asymptomatic rise in serum transaminases (AST/ALT) that occurs in approximately 10–20% of patients starting **Isoniazid (INH)**. This is a self-limiting phenomenon where the liver enzymes increase (usually <3 times the upper limit of normal) and then return to baseline even while the drug is continued. It represents a physiological adjustment of the liver to the drug metabolites rather than true hepatotoxicity. True INH-induced hepatitis is much rarer (1%) and requires drug discontinuation. **Analysis of Incorrect Options:** * **B. Rifampicin:** While Rifampicin is a potent inducer of microsomal enzymes and can cause dose-dependent cholestatic jaundice, it does not typically cause the specific "adaptation" phenomenon associated with INH. When used with INH, it increases the risk of hepatotoxicity by inducing enzymes that produce toxic metabolites. * **C. Pyrazinamide:** This is the **most hepatotoxic** drug among the first-line ATT. It causes dose-related hepatotoxicity and does not show a benign "adaptation" phase; any significant rise in enzymes usually necessitates immediate cessation. * **D. Ethambutol:** This drug is primarily excreted by the kidneys and is **not hepatotoxic**. Its primary side effect is optic neuritis (retrobulbar neuritis). **NEET-PG High-Yield Pearls:** * **Most Hepatotoxic ATT:** Pyrazinamide > Isoniazid > Rifampicin. * **Least Hepatotoxic/Safe in Liver Disease:** Ethambutol and Streptomycin. * **INH Toxicity:** Associated with peripheral neuropathy (prevented by Pyridoxine/Vit B6) and Sideroblastic anemia. * **Clinical Rule:** Stop ATT if Transaminases are >3 times normal with symptoms (nausea, jaundice) or >5 times normal if asymptomatic.

Q: Methenamine salts are used as urinary antiseptics. The reason they lack systemic antibacterial action is that they are :

Converted to formaldehyde at low urinary pH. ### Explanation **Concept:** Methenamine (hexamethylene tetramine) is a **prodrug** that lacks intrinsic antibacterial activity. Its mechanism of action is entirely dependent on its decomposition into **formaldehyde** and ammonia. This chemical conversion occurs only in an **acidic environment (pH < 5.5)**. Since physiological blood pH is approximately 7.4 (alkaline/neutral), methenamine remains stable and inactive in the systemic circulation. It is only when the drug is concentrated in the urine and the urine is acidified that formaldehyde is released. Formaldehyde is a non-specific denaturant of proteins and nucleic acids, providing the antiseptic effect. **Analysis of Options:** * **Option A (Incorrect):** Methenamine is well-absorbed orally but must be administered in enteric-coated tablets to prevent premature conversion to formaldehyde by gastric acid. * **Option B (Incorrect):** It is not significantly metabolized by the liver; it is excreted unchanged in the urine via glomerular filtration. * **Option D (Incorrect):** It is excreted primarily by glomerular filtration, not active tubular secretion. **Clinical Pearls for NEET-PG:** 1. **Urinary Acidifiers:** To ensure efficacy, methenamine is often co-administered with acidifying agents like **Vitamin C (Ascorbic acid)** or Ammonium chloride. 2. **Contraindication:** It is contraindicated in **Renal Insufficiency** because the mandelate or hippurate salts can cause systemic acidosis, and the drug cannot reach the bladder in therapeutic concentrations. 3. **Drug Interaction:** Do not co-administer with **Sulfonamides**; formaldehyde forms an insoluble precipitate with sulfonamides in the urine, increasing the risk of crystalluria. 4. **Spectrum:** It is a "universal" antiseptic; because formaldehyde's action is non-specific, resistance does not develop.

Q: What is the mechanism of action of chloramphenicol?

Cessation of peptide chain elongation. Chloramphenicol is a broad-spectrum, bacteriostatic antibiotic [1]. Its primary mechanism involves binding reversibly to the 50S ribosomal subunit at the peptidyl transferase site. By doing so, it inhibits the enzyme peptidyl transferase, which is responsible for forming peptide bonds between amino acids. Consequently, the addition of new amino acids to the growing polypeptide chain is blocked, leading to the cessation of peptide chain elongation. Analysis of Options: Option A (Incorrect): Preventing the binding of aminoacyl-tRNA to the A-site of the ribosome is the mechanism of Tetracyclines (which bind to the 30S subunit) [2]. Option B & D (Incorrect): Cell wall lysis and inhibition of cell wall synthesis are mechanisms characteristic of Bactericidal drugs like Beta-lactams (Penicillins, Cephalosporins) and Vancomycin. Chloramphenicol acts on protein synthesis, not the cell wall. High-Yield NEET-PG Pearls: 1. Resistance: Primarily mediated by the acquisition of a plasmid encoding chloramphenicol acetyltransferase, which inactivates the drug. 2. Gray Baby Syndrome: Occurs in neonates due to a deficiency of the hepatic enzyme glucuronyl transferase, leading to drug accumulation. 3. Bone Marrow Toxicity: Can cause dose-dependent suppression or idiosyncratic Aplastic Anemia (irreversible and fatal). 4. Spectrum: It is highly lipid-soluble and crosses the blood-brain barrier, making it historically significant for bacterial meningitis and enteric fever (though now limited by resistance and toxicity) [3].

Q: Which of the following drugs used in the treatment of AIDS patients is NOT known to cause bone marrow depression?

Didanosine. **Explanation:** The management of HIV/AIDS involves a combination of antiretroviral therapy (ART) and prophylaxis for opportunistic infections. A critical aspect of these treatments is monitoring for **bone marrow suppression (myelosuppression)**, which manifests as anemia, neutropenia, or thrombocytopenia. **Why Didanosine is the correct answer:** **Didanosine (ddI)** is a Nucleoside Reverse Transcriptase Inhibitor (NRTI). Unlike many other drugs in its class (like Zidovudine), its dose-limiting toxicity is **pancreatitis** and **peripheral neuropathy**, rather than myelosuppression. It is specifically noted for being relatively "bone marrow-friendly," making it a safer choice regarding hematological profiles. **Analysis of Incorrect Options:** * **Zalcitabine (ddC):** While its primary toxicity is peripheral neuropathy, it is known to cause significant bone marrow depression, particularly when used in combination with other myelosuppressive agents. * **Cotrimoxazole (TMP-SMX):** Frequently used in AIDS patients for *Pneumocystis jirovecii* prophylaxis, this drug inhibits folate metabolism, which commonly leads to megaloblastic anemia and leukopenia. * **Ganciclovir:** Used for CMV retinitis in AIDS patients, its most common and serious side effect is profound, dose-related neutropenia and thrombocytopenia. **NEET-PG High-Yield Pearls:** * **Zidovudine (AZT):** The most notorious NRTI for causing macrocytic anemia and bone marrow suppression. * **Mnemonic for Didanosine (ddI):** Remember the **"P"s**—**P**ancreatitis and **P**eripheral neuropathy (not **P**ancytopenia). * **Ganciclovir vs. Foscarnet:** Ganciclovir causes bone marrow suppression, whereas Foscarnet (the alternative for CMV) is primarily nephrotoxic.

Q: What is the drug of choice for acute pneumococcal lobar pneumonia?

Crystalline penicillin (Penicillin G). **Explanation:** **1. Why Crystalline Penicillin (Penicillin G) is the Correct Answer:** *Streptococcus pneumoniae* (Pneumococcus) remains the most common cause of community-acquired lobar pneumonia. Despite rising resistance patterns globally, **Crystalline Penicillin (Penicillin G)** remains the traditional **drug of choice (DOC)** for sensitive strains in an inpatient setting. It is highly bactericidal against *S. pneumoniae* by inhibiting cell wall synthesis. For acute, severe cases requiring hospitalization, intravenous Penicillin G ensures rapid therapeutic concentrations in the lung parenchyma. **2. Why the Other Options are Incorrect:** * **Amoxicillin-Clavulanic Acid:** While effective for community-acquired pneumonia (CAP) and often used as empirical therapy (especially if *H. influenzae* is suspected), it is not the specific DOC for confirmed pneumococcal lobar pneumonia. Clavulanic acid adds no benefit against *S. pneumoniae* because its resistance mechanism involves altered Penicillin-Binding Proteins (PBPs), not beta-lactamase production. * **Ciprofloxacin:** This is a "second-generation" fluoroquinolone with poor activity against Gram-positive organisms like *S. pneumoniae*. "Respiratory quinolones" (e.g., Levofloxacin, Moxifloxacin) are used instead. * **Co-trimoxazole:** There is widespread resistance of *S. pneumoniae* to sulfonamides, making it an unreliable choice for acute lobar pneumonia. **3. Clinical Pearls for NEET-PG:** * **DOC for Outpatient Pneumococcal Pneumonia:** Oral Amoxicillin. * **Mechanism of Resistance:** *S. pneumoniae* develops resistance to penicillin via **alteration of PBPs**, not by producing beta-lactamase. * **Drug of Choice for Penicillin-resistant Pneumococci:** Vancomycin or Linezolid. * **Rust-colored sputum** is a classic clinical hallmark of pneumococcal pneumonia.

Question 1

All of the following are common adverse effects of HAART therapy except?

Accepted Answer

Optic neuritis

Answer

Steatosis

Answer

Lipodystrophy

Answer

Increased cholesterol

Question 2

Reactivation of Varicella-Zoster Virus (VZV) is known to occur in persons receiving immunosuppressive therapy. Which of the following is the best antiviral for treating this infection?

Accepted Answer

Valacyclovir

Answer

Amantadine

Answer

Boceprevir

Answer

Ribavirin

Question 3

Which of the following drugs is not required in the treatment of cysticercosis?

Accepted Answer

Ketoconazole

Answer

Albendazole

Answer

Praziquantel

Answer

Levetiracetam

Question 4

Which of the following statement is not true regarding dapsone?

Accepted Answer

Poor oral absorption

Answer

It acts by inhibiting folic acid synthesis

Answer

It can cause DDS syndrome

Answer

Can cause hemolysis

Question 5

Pseudojaundice is an adverse effect of which of the following drugs?

Accepted Answer

Rifabutin

Answer

Phenytoin

Answer

Omeprazole

Answer

Chlorpromazine

Question 6

Which antitubercular drug causes hepatic adaptation?

Accepted Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Answer

Ethambutol

Question 7

Methenamine salts are used as urinary antiseptics. The reason they lack systemic antibacterial action is that they are :

Accepted Answer

Converted to formaldehyde at low urinary pH

Answer

Not absorbed into systemic circulation after oral use

Answer

Rapidly metabolized by liver drug metabolizing enzymes

Answer

Substrates for active tubular secretion

Question 8

What is the mechanism of action of chloramphenicol?

Accepted Answer

Cessation of peptide chain elongation

Answer

Preventing binding of tRNA to ribosome

Answer

Cell wall lysis

Answer

Inhibiting cell wall synthesis

Question 9

Which of the following drugs used in the treatment of AIDS patients is NOT known to cause bone marrow depression?

Accepted Answer

Didanosine

Answer

Zalcitabine

Answer

Cotrimoxazole

Answer

Ganciclovir

Question 10

What is the drug of choice for acute pneumococcal lobar pneumonia?

Accepted Answer

Crystalline penicillin (Penicillin G)

Answer

Amoxicillin clavulanic acid combination

Answer

Ciprofloxacin

Answer

Co-trimoxazole

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?